Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NBSE

NeuBase Therapeutics (NBSE) Stock Price, News & Analysis

NeuBase Therapeutics logo

About NeuBase Therapeutics Stock (NASDAQ:NBSE)

Advanced Chart

Key Stats

Today's Range
$0.38
$0.38
50-Day Range
$0.38
$0.38
52-Week Range
$0.36
$4.80
Volume
N/A
Average Volume
N/A
Market Capitalization
$1.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NBSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuBase Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

NBSE Stock News Headlines

Greenlight Capital Q3 2024 Letter
Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
See More Headlines

NBSE Stock Analysis - Frequently Asked Questions

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) posted its quarterly earnings data on Thursday, December, 23rd. The company reported ($4.20) EPS for the quarter, beating the consensus estimate of ($4.60) by $0.40.

Shares of NeuBase Therapeutics reverse split before market open on Thursday, June 15th 2023.The 1-20 reverse split was announced on Thursday, June 15th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 15th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that NeuBase Therapeutics investors own include Pfizer (PFE), Energy Transfer (ET), Sio Gene Therapies (SIOX), Avino Silver & Gold Mines (ASM), Actinium Pharmaceuticals (ATNM), Cytokinetics (cytk) and Enbridge (enb).

Company Calendar

Last Earnings
12/23/2021
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:NBSE
CIK
1173281
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
3,750,000
Free Float
3,456,000
Market Cap
$1.43 million
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:NBSE) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners